Social Support for Endometrial Cancer
(SISTER Trial)
Trial Summary
What is the purpose of this trial?
The SISTER study is a randomized trial, looking at various modalities of social support for Black patients undergoing treatment for endometrial cancer. There are three study arms: group support, 1:1 peer support, and enhanced usual care. The primary outcome is treatment completion, and the secondary outcome is social isolation.
Do I have to stop taking my current medications for the trial?
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.
What data supports the effectiveness of the treatment Social Support Intervention for Endometrial Cancer?
Research shows that peer support, including one-to-one and group support, is valued by cancer patients and can help reduce social isolation and improve coping skills. Studies on women with breast cancer have found that peer support provides emotional and informational benefits, suggesting it could be similarly beneficial for women with endometrial cancer.12345
Is social support safe for people with cancer?
How does the social support treatment for endometrial cancer differ from other treatments?
This treatment is unique because it focuses on providing emotional and informational support through one-to-one peer interactions, rather than traditional medical interventions. It aims to reduce psychological distress and improve quality of life by connecting patients with others who have experienced similar challenges.13678
Research Team
Kemi M Doll, MD, MSCR
Principal Investigator
University of Washington
Eligibility Criteria
The SISTER study is for Black adults over 18 with high-risk endometrial cancer, including various stages and grades, or recurrent endometrial cancer. Participants must be starting adjuvant therapy but can't join if they have contraindications to such therapies, other recent cancers treated within a year, the least aggressive type of this cancer (Stage IA Grade 1), are in custody/hospice, unable to consent or be contacted.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive chemotherapy, radiation, or immunotherapy along with social support interventions
Follow-up
Participants are monitored for treatment completion and social isolation
Treatment Details
Interventions
- 1:1 Peer Support
- Facilitated group support
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Washington
Lead Sponsor
Patient-Centered Outcomes Research Institute
Collaborator